Keep up with all the latest news about how TEDCO is helping grow the Maryland entrepreneur funding sector through investments, network of industry professionals, and educational resources.
News & Events
Events
TEDCO's Investment Open Forum
During this informative meeting, you’ll have the chance to hear from our investment team and ask
TEDCO's Venture Development Open Forum
Join TEDCO’s Venture Development team for a monthly Open Forum — a recurring lunchtime discussion
TEDCO’s BRIDGE Program Open Forum
Come to the Open Forum to learn more about TEDCO's BRIDGE program and how it connects you to advi
The Daily Record Icon Honors Awards
The Icon Honors awards recognize Maryland leaders over the age of 60 for their notable success an
TEDCO in the News
Stephen Auvil: Advancing Innovation Between Labs and Startups
Today's guest is Stephen Auvil, Chief Federal Engagement Officer at TEDCO, where he fosters connections and supports collaboration between industry and federal labs throughout Maryland. Stephen’s path began when an MBA class ignited his interest in combining science and business, shaping a career
LEARN MORE
Propelling Maryland's aerospace future: The synergy of MATC and MAA
Maryland's aerospace industry represents a formidable economic engine and a critical hub for national security and technological innovation. With 15 of the world’s top 20 aerospace and defense companies calling Maryland home, the state's capabilities span space exploration, satellite technology
LEARN MORE
TEDCO Invests in Higher Medicine
Higher Medicine is a company working to develop functional cures for Kabuki syndrome (KS) using epigenetic modifying molecules. The business aims to restore the open versus closed chromatin balance, the primary cause of KS, by using an LSD-1 inhibitor and accelerating into a patient clinical study.
LEARN MORE
TEDCO Invests in Higher Medicine
Higher Medicine, located in Baltimore, Md., is a company working to develop functional cures for Kabuki syndrome (KS) using epigenetic modifying molecules. The business aims to restore the open versus closed chromatin balance, the primary cause of KS, by using an LSD-1 inhibitor and accelerating
LEARN MORE